Ever found yourself wondering why everyone’s suddenly obsessed with matcha? That creamy, earthy, slightly bitter Japanese green tea has taken over Mumbai’s cafe scene and for good reason. Whether you’re a seasoned sipper or a total newbie, the city has plenty to offer. Here’s a freshly brewed guide to the best spots where matcha magic is being stirred up just right.
Best Matcha drink spots in Mumbai
Tokyo Matcha Bar & Cafe
If you’re serious about matcha, this is where it all begins. Tokyo Matcha Bar is Mumbai’s first dedicated cafe for matcha, located in the heart of Bandra. This spot nails the authenticity with a menu that ranges from classic hot teas to icy sea salt matcha frappes. The vibe is minimal and very Zen, just like a Japanese tea house.
Where: Pali Hill, Bandra West
Cost: Rs 600 for two
Mokai Cafe
Stylish and effortlessly cool, Mokai isn’t just about good aesthetics; it delivers on flavour too. Their crowd-pleasing iced vanilla matcha is smooth, lightly sweetened, and super refreshing, which keeps regulars coming back.
Where: Chapel Road, Bandra West
Cost: Rs 900 for two
Cravin’ by Andy
Located on the streets of Fort, Cravin’ by Andy offers a variety of matcha flavours in a cosy setting. While you can explore different variations, the velvety oat milk matcha latte with a subtle vanilla twist that’s almost dessert-like is a local’s top pick.
Where: Kala Ghoda, Fort
Cost: Rs 2,000 for two
Blondie
Tucked away in Khar, Blondie brings European charm to your morning routine. Their green drinks, especially matcha latte, are creamy and comforting without being overpowering. Settle in with your laptop or grab a pastry and let the calm vibes wash over you.
Where: Khar
Cost: Rs 1,600 for two
Booje Cafe
Not all matcha needs to be complicated. Booje keeps it simple, and that’s exactly why it works. With just the right level of sweetness and richness, their matcha drinks are perfect for anyone just stepping into the world of green tea.
XRP Price Predictions have been incredibly bullish recently as XRP price movements flash the same buy signals that preceded its explosive 500% rally from under $1 to over $5 in December 2024.
With Ripple price action currently around $3.55 and multiple technical indicators aligning bullishly, the cryptocurrency community is closely watching whether history will repeat itself.
The market is entering what many consider alt season territory and attention is now on whether the next big altcoin 2025 opportunity lies within XRP’s current setup, or are other high growth crypto on the horizon. Let’s dig in.
XRP Price Predictions: Ripple Technical Signals Mirror December Breakout Pattern
Technical analysis reveals striking similarities between current XRP chart patterns and those seen before Ripple price went parabolic.
Ripple’s TD sequential indicator has flashed multiple buy signals on the 4-hour chart, with the latest “9” formation suggesting trend exhaustion and potential reversal. Historically, this same indicator triggered XRP rallies between 6% and 26% following similar setups.
Current XRP Price Prediction models show the token trading within a rising channel, with support forming around $3.15-$3.20 and resistance targets at $3.30-$3.40.
Ripple’s volume analysis indicates significant whale activity near $2.38, with liquidation clusters building between $2.40-$2.45 that could trigger short squeezes if momentum accelerates.
Market Conditions Align for XRP Price Surge
The macroeconomic environment presents favorable conditions for XRP growth, with institutional adoption accelerating and regulatory uncertainty diminishing.
Ripple’s expansion into over 90 payout markets has processed more than $70 billion in transactions, while recent Dubai Financial Services Authority approval for RLUSD stablecoin demonstrates growing institutional acceptance.
Analysts note that XRP recently achieved its highest weekly close in history, breaking above the 2017-2018 all-time high band in a move that mirrors Bitcoin dominance patterns from late 2020.
Remittix: The DeFi Project Redefining Cross-Border Payments
While XRP Price Predictions are speculative and try to draw comparisons from previous rallies, Remittix is building real tech for individuals and businesses. The project’s recent wallet reveal and confirmed Q3 beta wallet launch positions it at the intersection of crypto innovation and real-world utility.
The Layer 2 Ethereum alternative’s focus on underserved remittance markets in Africa, Southeast Asia and Latin America demonstrates real-world problem-solving beyond typical DeFi project speculation and this has captured investor attention.
Why Whales Don’t Want To Miss out on Remittix
Multi-Chain PayFi Infrastructure: Native integration across Ethereum, Solana, and planned support for Cardano and XRP networks.
CertiK Security Validation: Comprehensive smart contract audit with no critical vulnerabilities found.
Deflationary Token Economics: Built-in burn mechanism reduces RTX supply with each transaction.
$17.4M+ Funding Achievement Backed by working infrastructure, not vaporware
Unlike projects that promise future utility, Remittix delivers working infrastructure today, making it an essential consideration for portfolios focused on next big altcoin 2025 opportunities with sustainable fundamentals and measurable adoption metrics.
Discover the future of PayFi with Remittix by checking out their project here:
DeBank VIP user AndreIsBack has executed a high-stakes DeFi strategy using Fluid, a decentralized finance protocol, to collateralize 16,448.13 ETH while borrowing $46.21 million in stablecoins across six distinct positions [1]. This move underscores the growing sophistication of leveraged trading in the Ethereum ecosystem, as users seek to maximize capital efficiency without liquidating their underlying crypto assets. By locking a substantial portion of ETH as collateral, AndreIsBack maintains long-term exposure to Ethereum’s price movements while accessing liquidity for secondary investments or trading. The strategy reflects a nuanced approach to risk management, leveraging multi-position borrowing to spread collateral and mitigate liquidation risks [1].
Blockchain analyst Ai Yi has highlighted this as a notable example of advanced DeFi practices, emphasizing the expanding role of protocols like Fluid in enabling liquidity management [1]. The use of stablecoins as borrowed assets allows users to maintain crypto holdings while capitalizing on short-term opportunities, a tactic that aligns with broader trends in decentralized finance. AndreIsBack’s approach also demonstrates confidence in Ethereum’s long-term value, as the user’s ETH collateral remains untouched despite the leveraged exposure.
The risks associated with such strategies are significant. If Ethereum’s price experiences a sharp decline, AndreIsBack’s collateral could face liquidation unless adjusted promptly. However, the multi-position structure—splitting borrowing across six separate loans—reduces the likelihood of total liquidation by distributing risk. This method allows for granular control over each position’s parameters, enabling tailored risk management in volatile markets [1].
Fluid’s role in facilitating this strategy is critical. As a DeFi protocol, it enables users to leverage their crypto assets by issuing stablecoins against collateral. The platform’s support for multi-position borrowing distinguishes it from single-loan models, offering users greater flexibility in optimizing liquidity while managing exposure. For experienced traders like AndreIsBack, such tools are essential for executing complex strategies that balance leverage with risk mitigation [1].
The implications for DeFi extend beyond individual tactics. This case illustrates how protocols are evolving to meet the demands of institutional-grade strategies, attracting high-net-worth users who seek advanced financial tools. As Ethereum’s ecosystem matures, the integration of sophisticated leverage mechanisms could redefine traditional investing paradigms. However, the reliance on stablecoin borrowing also raises questions about systemic risks, particularly in scenarios where stablecoin pegs face volatility.
AndreIsBack’s $46.21 million borrowing ranks among the largest leveraged positions in the DeFi space, showcasing the scale of capital flowing into decentralized platforms. While such strategies offer significant upside potential, they also highlight the need for robust risk management frameworks. The case serves as a microcosm of DeFi’s trajectory: a shift from speculative experiments to structured, high-conviction strategies that mirror traditional finance’s sophistication [1].
Source: [1] DeBank VIP AndreIsBack Uses Fluid to Long 16,448 ETH with $46M Stablecoin Borrowing (https://en.coinotag.com/breakingnews/debank-vip-andreisback-uses-fluid-to-long-16448-eth-with-46m-stablecoin-borrowing/)
Copper price is under negative pressures, which forces it to provide bearish correctional trading, but its stability above the support at $5.3200 forms the main factor to confirm the continuation of the positivity in the near and medium period trading, therefore, we will keep waiting for gathering the positive momentum to motivate it to target $5.7100, then wait to reach the next main target near $5.9700.
Note that the price decline below the mentioned support and holding below it, so that will confirm delaying the bullish scenario, to begin providing strong bearish correctional trading, to expect reaching $5.0650, then reach the next support base at $4.7200 level.
The expected trading range for today is between $5.4000 and $5.7100
The Pound to Dollar exchange rate (GBP/USD) has struggled to hold gains above 1.3450 as a firmer USD, boosted by the latest US-EU trade deal and upcoming Fed policy signals, weighs on near-term sentiment, though long-term forecasts, including from Wells Fargo, still point to a move towards 1.37 by end-2025.
The Pound-to-Dollar rate briefly hit 1.3450 in Asia on Monday before a retreat to test 1.3400 as the US currency gained net support following the US-EU trade deal.
Pound Sterling settled around 1.3430 as it attempted to resist a firm dollar and Sterling did have a firm tone on the crosses with net gains across most major pairs, notably the Euro.
ING sees the risk of further losses for the pair amid a firm US currency; “GBP/USD looks more vulnerable. Here, we favour a retest of decent support at 1.3370, below which losses can accelerate – perhaps all the way to 1.3150 if the US data/FOMC event risk this week is dollar positive enough.
According to UoB; “From here, we expect GBP to trade with a downward bias, but it is too early to determine if GBP can reach the major support at 1.3365.”
Wells Fargo sees scope for GBP/USD gains to 1.37 by the end of 2025 before a relapse to 1.30 by the end of 2026.
Overall risk appetite held firm with overall volatility grinding lower which helped underpin the Pound in global markets.
MUFG commented; “The biggest risk of market volatility that could undermine the positive FX carry momentum will come at the end of the week – with the release of the non-farm payrolls report.”
According to ING; “there is a huge amount of macro data and central bank action this week, which we think can provide some support to the dollar.
The Federal Reserve will announce its interest rate decision on Wednesday with strong expectations that rates will be held at 4.50%.
ING expects a mixture of solid data and residual inflation concerns will influence the decision.
It added; “This should leave the majority of the Federal Reserve comfortable in their patient position on interest rates (FOMC meeting on Wednesday) and see a further pricing out of the prospects of a September Fed rate cut.”
Markets remain very confident that the Fed will leave rates at 4.50%. There is the possibility of dissenting votes from Waller or Bowman and the guidance from Chair Powell will be watched very closely, especially given political pressure from the Administration.
According to Scotiabank; “For the statement, we note the risk of dovish dissents from both members of the board of governors as well as the regional Fed presidents.”
Rabobank commented; “US data release will be overshadowed by an FOMC decision. Has Trump’s visit to the Federal Reserve changed Powell’s mind? Have the recent trade deals – which bring lower tariffs than perhaps feared? And if not, will Powell’s reluctance to back a rate cut change Trump’s mind about letting the Fed Chair sit out his term?
It added; “Our US strategist expects the FOMC to stay on hold a little while longer, as they try to gauge the impact of tariffs on the US economy.”
According to MUFG; “Recent trade deals will be welcomed by the Fed as they help to dampen downside risks to growth and upside risks to inflation. We expect Chair Powell to continue to signal that they want to assess economic data over the summer to better determine the best path for policy going forward while sticking to plans to resume rate cuts later this year if inflation doesn’t surprise to the upside.”
ING also considers that the US Dollar is not an attractive funding currency, limiting potential selling pressure.
Like this piece? Please share with your friends and colleagues:
International Money Transfer? Ask our resident FX expert a money transfer question or try John’s new, free, no-obligation personal service! ,where he helps every step of the way,
ensuring you get the best exchange rates on your currency requirements.
TikTok beauty influencer Kaycee Ogle is regularly contacted by brands who want her to promote their products. But one email she received in June was different, and made her curious.
“We’ve been impressed by your amazing content and would love to explore a collaboration with you!” the agency representative began.
The company wanted Ogle to promote one of their newer products: a small circular skin patch that claims to “support healthy weight management and appetite control.” Called “GLP-1 Patches,” the brand says the patch increases production of glucagon-like peptide-1, sometimes considered the satiety hormone, after two months of use.
Supplement manufacturers have capitalized on the explosive popularity of diabetes control and weight loss drugs such as Ozempic, Wegovy and Zepbound by flooding the market with their own pills, powders, drops and patches bearing “GLP-1” branding.
But experts say that while the efficacy of those supplements can vary, none are remotely as effective as the GLP-1 agonist medications semaglutide and tirzepatide, and the lack of regulatory oversight makes it hard for consumers to know exactly what they are purchasing and using.
The wide world of weight loss products ranges from legitimate medications, to compounded drugs offered by telehealth companies, to the gray market of online peptides, and supplements. That last category alone includes supplements claiming to replace GLP-1 agonists completely, “natural” versions of GLP-1 agonists that may work but be substantially less effective, and supplements intended to be taken alongside prescription medicine to “boost” GLP-1 production.
“The marketing seems to suggest that you could get with these natural products, these natural ingredients, the same effect that you can get with GLP-1 agonists, which is simply not the case. And in that way, they are being misleading to people,” said C. Michael White, professor of pharmacy practice at the University of Connecticut School of Pharmacy.
“Some of them don’t even tell you what ingredients are in it at all. And in those products, somebody may actually believe that they are going to get semaglutide or they are going to get tirzepatide.”
Ogle comes from a family of nurses, and prides herself on remaining honest, sticking to the facts and caring about the well-being of her viewers. She values their trust, which has helped her account and business thrive. So before she made any videos, she went looking for answers.
Capitalizing on the GLP-1 craze
GLP-1 is a hormone the body produces naturally that, among other roles, helps communicate satiety to the brain. GLP-1 agonists mimic the hormone and stimulate its receptor to trigger the same effect, which can aid weight loss by lowering appetite.
GLP-1 agonists have been around for decades, but in recent years, they’ve become almost culturally inescapable, thanks in particular to the success of Ozempic, Novo Nordisk’s injectable semaglutide that’s prescribed for patients with type 2 diabetes.
Two of the major prescription weight loss medications, semaglutide sold by Novo Nordisk as Wegovy and tirzepatide sold by Eli Lilly as Zepbound, are typically injected once a week. But they’re also expensive, costing hundreds of dollars a month out of pocket, and often not covered by insurance.
That leaves a hole in the consumer market. Many people know about these drugs and how they affect weight loss, appetite control and “food noise.” But many can’t afford them, don’t like the idea of injecting drugs, or can’t tolerate the side effects, said Bryn Austin, professor of social and behavioral sciences at the Harvard T.H. Chan School of Public Health.
Enter supplements. Austin said that “from Day One,” supplement companies have tried to capitalize on the GLP-1 craze, putting the phrase in their product names. That’s deceptive, she said.
“Any consumer that sees that will think, ‘Oh, it must work like Ozempic,’” she said.
FILE PHOTO: The wide world of weight loss products ranges from legitimate medications, to compounded drugs offered by telehealth companies, to the gray market of online peptides, and supplements. On TikTok, users can buy drops, patches, pills and powders with GLP-1 branding. Photo by Getty Images
The supplements, however, do not perform nearly as well as GLP-1 agonists, White said. One ingredient often used in supplements is berberine, which researchers have found can aid in weight loss. But a meta-analysis by the European Society for Clinical Nutrition and Metabolism found that patients taking berberine lose a little over 4 pounds on average. Other ingredients can help with between 1 and 3 pounds, White added.
“So we’re not talking about the 20-something-pound weight loss that you actually get with a real GLP-1 agonist,” he said.
Nonetheless, those who promote the alternative products online often refer to them in the same context as the injectable medications, sometimes calling them “‘Zempic patches” or “natural” versions of the GLP-1 agonists. Some seem excited about the ingredients, the price or the lack of side effects. Some are also paid per sale.
The agency that contacted Ogle told her that she would be given “full creative support from start to finish,” including a script, ad support and free samples.
But Ogle wasn’t sure. She’d felt deceived in the past, promoting a nutritional powder she later learned was ineffective, and which she later disavowed. She replied to the email, asking whether their “GLP-1 Patch” product was approved by the Food and Drug Administration, and why the company advised her against using words like “Ozempic,” “weight loss,” “blood sugar” and “GLP-1” in promotional content. They never responded to her, Ogle said.
Ultimately, Ogle decided to make a TikTok video, but instead of promoting the patches, she warned prospective consumers.
“It’s just tricking people into wasting their money for something that’s not actually working,” she said in the video.
How safe and effective are GLP-1 supplements?
While pharmaceuticals released in the U.S. are legally required to undergo rigorous safety and efficacy testing and must be approved by the FDA, the same rules do not apply to supplements.
In 1994, Congress passed the Dietary Supplement Health and Education Act, which defined dietary supplements and created a regulatory framework that largely bypasses the FDA. Unlike the safety and efficacy testing mandated for drugs, supplement manufacturers are generally not required to provide safety evidence before releasing a product, with some exceptions.
Ultimately, “manufacturers and distributors have initial responsibility for ensuring that their dietary supplements meet the safety standards,” according to the FDA.
“The FDA cannot require rigorous pre-screening for safety and certainly not for effectiveness because by law, these supplements cannot claim to be treating or curing or preventing disease. And yet any consumer seeing the kind of marketing and claims on packages would likely infer that many of them do have those effects,” Austin said.
The bottom line, Austin said, is companies selling GLP-1 supplements don’t have to test their products in clinical trials or prove that they increase hormone production, reduce cravings, control appetite or quiet food noise.
“They are not required to provide any evidence before they go to a market,” she said.
FILE PHOTO: In 1994, Congress passed the Dietary Supplement Health and Education Act, which defined dietary supplements and created a regulatory framework that largely bypasses the FDA. Compared to other supplements, experts say products marketed for weight loss have a long history of being adulterated, sometimes including extreme levels of stimulants. Photo by Getty Images
Companies do have to tell the FDA that they have evidence, said Jensen Jose, regulatory counsel for the Center for Science in the Public Interest. But they don’t actually have to provide that evidence, he said.
In response to PBS News’ request for an interview with the FDA, the Department of Health and Human Services pointed to a page on the FDA’s website about using unapproved GLP-1 drugs for weight loss.
Compared to other supplements, experts say products marketed for weight loss have a long history of being adulterated. That can mean the products contain FDA-approved drugs that are illegal to use in supplements, extreme levels of stimulants and even experimental stimulants not approved for human use, all of which have shown up in supplements, Austin said.
The Federal Trade Commission’s guidelines for health-related products require manufacturers to comply with a set of rules when using studies to market their products. This includes disclosing how the dosage and formulation of advertised products compares to studied products, whether ingredients in the advertised product are the same as what was used in the study and whether advertised products and studied products are administered in the same manner.
While some supplement websites cite studies, they don’t always meet these guidelines.
The company that reached out to Ogle, for example, references studies supporting the use of berberine, glutamine and chromium for weight loss, food intake and satiety. But the company’s patches are applied to the skin, while the studies for glutamine and chromium involved oral intake. The study cited for berberine was the meta-analysis, which encompassed many different studies where the administration methods are not always clear.
Many companies also don’t cite any studies where all the major ingredients found in its “GLP-1 Patch” are tested together, an important step in proving efficacy since certain ingredients can work against one another, said Caitlin Dow, nutrition scientist at the Center for Science in the Public Interest.
White said the science is not clear on how effectively a patch could administer these ingredients. In animal studies, transdermal patches have shown some promise in increasing bioavailability, or the body’s ability to access and use the ingredients compared to oral doses for ingredients like berberine and turmeric, he said.
“What we don’t have, at least not in the literature, is anybody that studied these products in humans in a transdermal patch formulation in order to be able to show that what they’re seeing in animals is actually being replicated in humans,” White said. “We would imagine that the results would likely be similar and that you would get more, but how much more, and what is a safe dose for you to be able to take?”
That kind of information is key, he added, because some ingredients could interfere with others users might be taking for problems like diabetes or heart disease.
“It may be more dangerous to be taking the products in this way than it would be to be taking them orally,” White said.
FILE PHOTO: Many companies also don’t cite any studies where all the major ingredients found in its “GLP-1 Patch” are tested together, an important step in proving efficacy since certain ingredients can work against one another, Dow said. Some ingredients could also interfere with others users might be taking for problems like diabetes or heart disease. Photo by Getty Images
In online reviews, some users of transdermal patches say the patches irritated their skin or left a rash.
Patches are a particularly thorny delivery method, because supplements by the FDA’s definition must be swallowed. Because patches are not supplements, Jose said, it’s not clear whether they would be classified as a cosmetic or drug (or possibly both).
The FTC can also step in if it believes companies have crossed an advertising line. In 2007, the FTC fined Transdermal Products International Marketing Corporation and its owner $180,000 and banned further sales, saying “advertising claims for their weight-loss patches were false and unsubstantiated.”
White said if someone is interested in taking any kind of supplement, they should look for products that have been reviewed, verified or certified by U.S. Pharmacopeia, NSF or ConsumerLab, which test supplements for adulterants or heavy metals.
TikTok ‘influencer economy’ raises concerns
TikTok users can scroll through video after video advertising weight loss supplements. In many of those videos, you can also tap a link at the bottom of the screen that will take you to the TikTok Shop, where purchases can be made directly in the app. Creators who are TikTok Shop affiliates, like Ogle, earn commission on products they promote and sell through the app.
Affiliates can see a range of details about a product, including the product’s net weight, quantity per pack, shelf life and whether it needs a dietary supplement disclaimer. Creators can also see how well the product is selling and how much commission they can make on each sale.
According to screenshots Ogle shared with PBS News, the product she was asked to promote was the top-selling item in its category on July 25, and creators could earn $2.97 for every sale of a 30-pack. Patches are sold for around $15, and more than 250,000 packs have been sold, according to publicly available numbers on TikTok’s shop. The patches have a four-star review average, with 9,100 reviews.
Patches aren’t the only kinds of “GLP-1” products available in the TikTok Shop — users can find drops, powders and pills — nor are GLP-1 branded supplements the only products claiming to help with weight loss. Yerba Mate in particular has found a niche on TikTok, where creators sometimes call it “nature’s Ozempic.”
While supplements bearing GLP-1 branding are sold on websites beyond social media platforms, TikTok stands out by allowing viewers to shop directly from the promoted content without leaving the app. Some videos have tens of thousands of views.
Some, however, have only a handful of views, and that can reflect the struggle promoters sometimes face, Austin said.
“A lot of people on social media posting and trying to be influencers are just trying to cover the groceries, their rent, they have a patchwork of jobs that they’re piecing together to support their families,” she said.
“The way the influencer economy works is they need to follow certain kinds of rules that will get the algorithm to pick them up, to get more amplified, to get more engagement, and to attract the attention and approval of these companies. And for many of them, it’s just about trying to get by. And it’s pushing them toward posting in a way that is deceptive.”
Ogle too finds it difficult to blame affiliates and influencers, many of whom may believe the claims they’re advertising.
“A lot of people see [the] success that a lot of us TikTok Shop affiliates have had, and it has been life-changing. So the brands recognize that, and they can manipulate people who don’t really know how it works yet,” Ogle said. “” think a lot of people don’t have ill intention, but when they find out something didn’t work, it’s okay to just be human and say, ‘Hey, I wasn’t aware, now I am.’”
Health experts interviewed for this story worry about the effect these videos can have on vulnerable people, including children, people prone to eating disorders and people concerned about their weight.
Years ago, consumers wanting to buy weight loss supplements had to seek out ads in magazines or physically find one of these products, Austin said. Now, anyone who lingers on or engages with a weight loss video might find themselves caught in promoted content loops, thanks to social media algorithms.
“It would be like all day, every day, you had salespeople for these supplements knocking on your door and finding you,” she said.
“If somebody needs extra help losing weight, and that’s something they actually need, they should be talking to a doctor in a clinical setting. They shouldn’t be preyed upon on something like TikTok,” Ogle said.
“I love TikTok. I love the ability to be able to sell and to be able to buy on there,” Ogle said. But she believes products like the “GLP-1 Patch” are cause for concern: “I think it’s outright dangerous because there’s not enough information on them to know what effects those are having long term on people.”
If you’ve taken a GLP-1 branded supplement, or purchased a weight loss supplement on social media, and would like to share your experience, PBS News wants to hear from you. You can email Hannah at hgrabenstein@newshour.org.
We’re not going anywhere.
Stand up for truly independent, trusted news that you can count on!
Solana is testing a key resistance zone after record institutional inflows and ARK Invest’s strategic staking move, signaling a potential breakout.
Under the surface of Solana’s recent price movement lies a mix of structural strength and institutional momentum. The announcement of ARK Invest’s institutional staking partnership, along with a record $311 million in weekly inflows, is having a major positive impact on price.
Currently hovering near the $190 to $194 resistance zone, Solana is testing a region that could determine whether the asset reclaims its bullish trend or pauses for consolidation.
ARK Invest Taps SOL Strategies for Institutional Solana Staking
In a notable move for the Solana ecosystem, Cathie Wood’s ARK Invest has officially partnered with SOL Strategies to handle its institutional staking needs through the Digital Asset Revolutions Fund. This is a major achievement for the Solana ecosystem. ARK Invest manages over $20 billion in assets under management.
Solana secures institutional backing as ARK Invest partners with SOL Strategies for high-volume staking operations. Source: SOL Strategies via X
Beyond the validation it brings, this kind of institutional involvement often translates into stronger price support. Large-scale staking operations reduce circulating supply, tightening available tokens on the market. Paired with ARK’s credibility, this could spark renewed investor interest and push Solana further into the spotlight.
Solana Sees Record $311M Weekly Inflows as Institutions Pour In
After a major bullish development, Solana just logged its largest-ever weekly inflow, $311 million across ETPs, ETFs, and funds, according to CoinShares data. That’s not just a new high, it’s three times the previous record. The scale of capital rotation suggests deeper institutional conviction, particularly at a time when other top assets like Bitcoin saw outflows.
Solana logs a record $311M in weekly inflows, tripling its previous high and signaling rising institutional conviction. Source: SolanaFloor via X
This kind of volume can’t be ignored on the price front. With $551 million in inflows month-to-date, and momentum still building, the surge could put consistent upward pressure on SOL’s market value.
Solana Pushing Through Sell Wall With Eyes on $235
Solana is now testing a key resistance band between $190 and $194, an area that previously acted as a sell wall and short-term ceiling. As highlighted by CW8900, this zone represents the first major hurdle before the next liquidity cluster, located around $210 and then $235.
Solana challenges key resistance at $194 as volume builds, with $235 eyed as the next major liquidity target. Source: CW8900 via X
The current structure shows a steady climb backed by rising volume, and price is attempting to pierce through this supply region with multiple intraday rejections already absorbed.
This technical breakout attempt comes on the heels of back-to-back bullish catalysts, including ARK’s institutional staking adoption and a record $311 million in weekly inflows. If SOL can secure a clean close above the $194 range, momentum could quickly extend toward the $210 mark, with $235 remaining the higher-timeframe target should the rally continue.
Solana Fractal Structure Suggesting Breakout Above All-Time High
Solana’s weekly chart is starting to show signs of something bigger unfolding. Trader Tardigrade outlines a compelling long-term structure where price action has been compressing in a wide accumulation range, marked by two failed breakout attempts on both sides.
Solana’s weekly fractal hints at a breakout past $260 as accumulation structure tightens and key levels come under pressure. Source: Trader Tardigrade via X
These “false moves” have helped establish well-defined horizontal boundaries, which are now being tested again. With the recent institutional inflows and price reclaiming key zones, the probability of a real breakout, rather than another trap, is increasing.
If SOL clears the upper boundary of this weekly range, the path opens towards its former all-time high around $260, with potential for fresh price discovery beyond that.
Contrary Views: ABC Correction Still on the Table for Solana
While momentum has favored the bulls lately, not all traders are ruling out the possibility of a near-term pullback. As highlighted by OxonTrading, Solana’s 4H chart may be shaping up into a textbook ABC corrective wave. With waves (A) and (B) seemingly completed, a potential (C) leg could drag price back toward the $172 to $174 region before the uptrend resumes. This zone also aligns with previous intraday support, making it a reasonable technical target for a short-term dip.
Solana’s 4H chart may be forming an ABC corrective wave, with a potential dip toward $172–$174 before trend continuation. Source: OxonTrading via X
This perspective offers a more cautious counterbalance to the recent bullish flood, especially after SOL’s aggressive push into the $190 resistance band. Even in trending markets, ABC corrections are common and healthy, allowing the market to reset leverage and sentiment.
Final Thoughts: Is Solana Poised for a Breakout or a Breather?
Solana’s recent surge, backed by institutional inflows, ARK Invest’s strategic entry, and a technically strong setup, has brought it to a critical tipping point. With $311M in weekly inflows and the $190 to 194 zone under attack, bulls are clearly in control for now. If SOL pushes past $194 and holds, the door toward $210 and eventually $235 could swing wide open, especially with momentum and liquidity aligning on higher timeframes.
That said, not everyone’s buying the hype without caution. The possibility of a short-lived ABC correction remains on the radar, with $172 to $174 offering a likely reset zone.
XTrade.gg, a high-performance DeFi trading terminal, hosted Degen Day Vietnam as a side event during GMVietnam Hanoi, aiming to connect traders and Web3 builders through a mix of educational content, networking, and interactive activities [1]. The event, held in Hanoi, featured alpha talks, mini-games, food and drinks, and direct engagement sessions with the XTrade team. Attendees were offered early access to market insights and strategies from key opinion leaders, while also testing the platform’s features and providing feedback [1].
The platform, optimized for Solana and Hyperliquid ecosystems, emphasizes speed, MEV (maximal extractable value) protection, and advanced token discovery tools. It also highlights competitive referral incentives and cashback programs to attract users [1]. During the event, XTrade showcased its capabilities as a one-stop solution for both novice and experienced traders, leveraging its closed beta success—reportedly serving 3,000+ users—with backing from Y Combinator alumni and Web3 industry veterans [1].
The event aligns with growing interest in DeFi adoption, particularly in Southeast Asia, where GMVietnam Hanoi serves as a hub for crypto enthusiasts. By hosting Degen Day Vietnam, XTrade.gg positions itself as a bridge between emerging markets and global Web3 innovation. The inclusion of mini-games and prize giveaways underscores the platform’s focus on gamifying user engagement, a trend gaining traction in the DeFi space [1].
The press release notes XTrade’s emphasis on community feedback as a core development strategy, reflecting broader industry shifts toward user-centric design in DeFi protocols. While the platform’s closed beta has demonstrated strong early traction, the event signals an expanded push to solidify its position in competitive trading markets. The absence of specific user growth metrics or funding details in the provided content leaves room for further analysis on XTrade’s scalability and long-term market viability [1].
Source: [1] XTrade.gg Hosts “Degen Day Vietnam” – The Ultimate Side Event at GMVietnam Hanoi Beyond Alpha [https://coinmarketcap.com/community/articles/6888541aee68857097c35340/].
The global Ascorbic Acid Market, commonly known as Vitamin C, has witnessed significant growth in recent years, driven by increasing consumer awareness regarding health, immunity, and wellness. According to the report from Persistence Market Research, the ascorbic acid market is expected to grow from USD 199.3 billion in 2024 to USD 321.5 billion by 2032, reflecting a robust CAGR of 6.2% during the forecast period. This growth trajectory can be attributed to a variety of factors, including the expanding use of ascorbic acid in food and beverage, pharmaceuticals, and cosmetics, along with its growing application as an antioxidant.
✅ Overview of the Market, Market Statistics, Key Growth Drivers, and Leading Segment
Ascorbic acid, also known as Vitamin C, is a water-soluble vitamin with antioxidant properties, widely used in the food and beverage, pharmaceutical, and cosmetic industries. The market for ascorbic acid is set to witness substantial growth from USD 199.3 billion in 2024 to USD 321.5 billion by 2032, representing a CAGR of 6.2% over the forecast period. This growth can be attributed to its increasing use as a nutritional supplement, preservative, and antioxidant across various sectors. The market is influenced by changing consumer preferences toward healthy and functional foods, the rise of immunity-boosting products, and a growing demand for natural and organic ingredients.
Get a Sample Copy of Research Report (Use Corporate Mail id for Quick Response): https://www.persistencemarketresearch.com/samples/7235
In particular, the food and beverage industry remains a leading end-user of ascorbic acid, primarily due to its ability to maintain freshness, prevent oxidation, and preserve the quality of food products. In addition to this, ascorbic acid plays an essential role in supporting the immune system, which has increased its popularity in the pharmaceutical and nutraceutical sectors. Geographically, North America and Europe dominate the ascorbic acid market, driven by high consumption rates of fortified foods and dietary supplements. However, the Asia-Pacific region is expected to exhibit the highest growth rate during the forecast period, primarily due to increasing urbanization, rising disposable incomes, and growing awareness of health and wellness.
✅ Key Highlights from the Report:
➤ The global ascorbic acid market is projected to grow from USD 199.3 billion in 2024 to USD 321.5 billion by 2032.
➤ The market is expected to register a CAGR of 6.2% during the forecast period (2024-2032).
➤ The increasing demand for Vitamin C-based supplements and antioxidants is a key factor driving market growth.
➤ The food and beverage industry remains the largest consumer of ascorbic acid.
➤ The pharmaceutical sector is experiencing significant growth due to rising health-conscious consumer behaviors.
➤ The Asia-Pacific region is expected to witness the highest growth rate in the coming years.
📊 Market Segmentation
The ascorbic acid market can be segmented based on application, product type, and end-user. Application-based segmentation includes dietary supplements, food and beverages, pharmaceuticals, and cosmetics. Among these, dietary supplements account for the largest share, as consumers increasingly seek natural ways to boost immunity and overall health. Ascorbic acid is also extensively used as an antioxidant in the food and beverage industry, where it prevents the oxidation of fats and oils, thereby improving shelf life and maintaining nutritional quality. Additionally, ascorbic acid is used in pharmaceutical applications, particularly in the formulation of immune-boosting supplements and in the treatment of deficiencies.
In terms of product types, the market includes natural and synthetic ascorbic acid. Natural ascorbic acid, derived from plant-based sources such as citrus fruits and other vegetables, is witnessing higher demand due to the growing preference for organic and natural ingredients. However, synthetic ascorbic acid, which is produced through chemical processes, remains dominant due to its cost-effectiveness and higher availability in large quantities. The end-user segmentation reveals that the food and beverage sector is the largest consumer, followed by pharmaceuticals and cosmetics. Ascorbic acid’s role in skin care formulations as an antioxidant and anti-aging agent is boosting its demand in the cosmetics industry, particularly in the formulation of serums and creams.
📊 Regional Insights
North America dominates the ascorbic acid market, with the U.S. being the leading consumer due to high demand for fortified foods, dietary supplements, and functional beverages. The rising awareness regarding the health benefits of ascorbic acid, coupled with the increasing demand for immunity-boosting products, has created a large market for ascorbic acid-based supplements and food items. Additionally, the growing consumer interest in preventive healthcare and holistic wellness contributes to the market’s expansion.
Europe follows closely, driven by increasing health-conscious consumers and the well-established pharmaceutical and food industries. Countries such as Germany, the UK, and France have seen a rise in demand for functional foods, nutraceuticals, and vitamins, contributing to the growth of the ascorbic acid market. The growing popularity of natural and organic products, as well as the increasing aging population, further supports market growth in this region. Meanwhile, the Asia-Pacific region is expected to see the highest growth rate during the forecast period, largely due to urbanization, rising disposable incomes, and an increasing focus on wellness and healthy aging. Additionally, the growing trend of preventive healthcare is increasing the demand for ascorbic acid in dietary supplements.
Explore a wide range of in-depth market insights and detailed reports available on our website for further information and analysis: https://www.persistencemarketresearch.com/market-research/ascorbic-acid-market.asp
✅ Market Drivers
Several factors are driving the growth of the ascorbic acid market. One of the primary drivers is the increasing demand for nutritional supplements. Ascorbic acid, known for its immunity-boosting properties, is increasingly being used in dietary supplements aimed at supporting overall health and wellness. The rise of preventive healthcare, where individuals focus on boosting their immunity to avoid illnesses, is further accelerating the demand for ascorbic acid-based supplements.
Another key driver is the food and beverage sector, where ascorbic acid is used as a preservative and antioxidant. The demand for processed, packaged, and functional foods is rising globally, which increases the need for ascorbic acid to enhance shelf life, prevent oxidation, and preserve flavor and nutrients. Ascorbic acid’s use in improving the quality of fruits, juices, and beverages is expected to fuel growth in this sector.
The cosmetics industry is also a significant growth driver for the ascorbic acid market. Ascorbic acid is used in a variety of skincare products due to its ability to fight free radicals, reduce signs of aging, and brighten skin. With the growing demand for anti-aging and skin-brightening products, the cosmetics sector presents a substantial opportunity for market expansion.
✅ Market Restraints
Despite the promising growth outlook, the ascorbic acid market faces several challenges. One of the primary restraints is the fluctuating raw material costs. The primary source of ascorbic acid is citrus fruits, but the availability of raw materials may vary depending on climatic conditions, affecting production costs and availability. Additionally, synthetic ascorbic acid, while more cost-effective, may face challenges from consumer preference for natural products, which are perceived to be healthier and more sustainable.
Another constraint is the competition from alternative products. Other vitamins, such as Vitamin E, and antioxidants, like beta-carotene, are increasingly being used in supplements and food products, which can limit the demand for ascorbic acid. The presence of these alternatives, along with the rising consumer preference for organic and natural ingredients, poses a challenge for the ascorbic acid market, especially in regions where consumers are becoming more health-conscious.
✅ Market Opportunities
The growing trend of functional foods presents a significant opportunity for the ascorbic acid market. Consumers are increasingly seeking foods that not only offer basic nutrition but also provide added health benefits, such as immunity-boosting properties. Ascorbic acid, with its antioxidant properties, fits perfectly into this trend, opening up opportunities for new product development in beverages, snacks, and fortified foods.
The expanding cosmetics industry presents another opportunity for the ascorbic acid market. With growing consumer demand for natural skincare products and anti-aging solutions, ascorbic acid’s antioxidant and skin-brightening properties make it an essential ingredient in many beauty products. Companies focusing on the development of natural and organic skincare lines are likely to increase their demand for ascorbic acid.
Additionally, emerging markets in regions such as Asia-Pacific and Latin America present a growth opportunity for the ascorbic acid market. With improving living standards, rising disposable income, and increasing awareness of health and wellness, these regions offer untapped potential for both dietary supplements and functional foods.
Do You Have Any Query Or Specific Requirement? Request Customization of Report: https://www.persistencemarketresearch.com/request-customization/7235
👉 Five Compelling Reasons to Buy the Report:
✔️ Gain valuable insights into the global market size, trends, and forecast projections up to 2032.
✔️ Identify key growth drivers and emerging opportunities that can help shape your business strategies.
✔️ Understand the competitive landscape and strategies of top players in the ascorbic acid market.
✔️ Discover growth opportunities in high-potential regional markets such as Asia-Pacific and Latin America.
✔️ Access detailed analysis of market challenges and restraints to make informed decisions.
📌 Key Players:
Key players operating in the global ascorbic acid market include:
✦ DSM Nutritional Products
✦ Adisseo
✦ BASF SE
✦ Kemin Industries, Inc.
✦ Cargill, Inc.
Recent Developments:
■ BASF SE announced the expansion of its production capacity for ascorbic acid to meet the growing demand in the Asia-Pacific market.
■ Kemin Industries recently launched a new line of ascorbic acid-based antioxidants for the food industry, emphasizing sustainability and high-quality preservation solutions.
☎️ Contact Us:
Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com
About Persistence Market Research:
At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies’ clients.
Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we’ve built over the years.
The rate of Ethereum ETHUSD has dropped by 0.6% over the last day.TradingView”>
On the hourly chart, the price of ETH has fixed below the local support of $3,843. If bulls cannot seize the initiative until the end of the day, the correction is likely to continue to the $3,700 mark.TradingView”>
On the longer time frame, the rate of the main altcoin has made a false breakout of yesterday’s bar high.
If nothing changes by the end of the day, traders may witness a test of the $3,600-$3,700 range shortly.TradingView”>
From the midterm point of view, one should pay attention to the weekly candle closure. If it happens far from the $3,900 zone, bears may come back to the game, which may lead to a drop to the $3,500 mark.
